Skye Bioscience (SKYE) Tax Provisions (2013 - 2026)

Skye Bioscience (SKYE) has reported Tax Provisions for 14 consecutive years, with $3400.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions changed 0.0% year-over-year to $3400.0 in Q2 2026; TTM through Jun 2026 was $3400.0, a 37.04% decrease from a year earlier, with the FY2025 full-year figure at $5400.0, down 46.38% from the prior year.
• Tax Provisions was $3400.0 for Q2 2026 at Skye Bioscience, roughly flat from $3400.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $8071.0 in Q2 2024 and troughed at $1600.0 in Q4 2022.
• A 5-year average of $3651.5 and a median of $3400.0 in 2025 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 221.31% in 2022 and slumped 57.87% in 2025, its largest moves.
• Over 5 years, Tax Provisions stood at $1600.0 in 2022, then jumped by 125.0% to $3600.0 in 2023, then jumped by 124.19% to $8071.0 in 2024, then tumbled by 57.87% to $3400.0 in 2025, then changed by 0.0% to $3400.0 in 2026.
• The last three Tax Provisions figures came in at $3400.0 (Q2 2026), $3400.0 (Q2 2025), and $2000.0 (Q1 2025), per Business Quant data.